Andorra Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Andorra Health Watch.

Press releases published on May 26, 2026

May 26, 2026

MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City

Indeterminate GlobeNewswire

May 26, 2026

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

May 26, 2026

Calidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

May 26, 2026

LENZ Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

May 26, 2026

Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia

Indeterminate GlobeNewswire

May 26, 2026

Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy

Indeterminate GlobeNewswire

May 26, 2026

Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza

Indeterminate GlobeNewswire

May 26, 2026

Humacyte Announces Presentation at VASA Meeting of Research Highlighting Self-Repair of ATEV After Cannulation for Dialysis Access

Indeterminate GlobeNewswire

May 26, 2026

Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer

Indeterminate GlobeNewswire

May 26, 2026

Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions

Indeterminate GlobeNewswire

May 26, 2026

Progyny, Inc. Announces Share Repurchase Program

Indeterminate GlobeNewswire

May 26, 2026

Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire

May 26, 2026

Annovis Bio Regains NYSE Listing Compliance

Indeterminate GlobeNewswire

May 26, 2026

Brain Cancer Canada Invests $50,000 in Promising Immunotherapy Breakthrough Targeting One of the Most Aggressive Brain Tumours

Indeterminate GlobeNewswire

May 26, 2026

Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026

Indeterminate GlobeNewswire

May 26, 2026

Kraig Biocraft Laboratories Smashes Production Targets as New Spider Silk Batch Surges Past Expectations

Indeterminate GlobeNewswire

May 26, 2026

J-Star Holding Subsidiary Receives Central Bank of Taiwan Authorization to Initiate $60 Million Sovereign-Backed Financing Framework through Designated Banks for U.S. Solid-State Battery Expansion ($122.5 Million Project)

Indeterminate GlobeNewswire

May 26, 2026

Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases

Indeterminate GlobeNewswire

May 26, 2026

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

Indeterminate GlobeNewswire

May 26, 2026

Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)

Indeterminate GlobeNewswire